首页|期刊导航|遵义医科大学学报|趋化因子受体4拮抗多肽对Ⅰ型神经纤维瘤病细胞增殖与迁移的抑制作用

趋化因子受体4拮抗多肽对Ⅰ型神经纤维瘤病细胞增殖与迁移的抑制作用OA

The inhibitory effects of the chemokine receptor 4 antagonist peptide on the proliferation and migration of neurofibromatosis type 1 cells

中文摘要英文摘要

目的 筛选与儿童NF1细胞具有较强结合作用的趋化因子受体4(CXCR4)拮抗多肽,研究其抗儿童Ⅰ型神经纤维瘤病(NF1)细胞增殖及迁移的能力,并揭示其潜在机制.方法 以NF1患者来源的细胞系WZJ为研究对象,利用流式细胞仪检测细胞中CXCR4受体的表达及多肽与细胞的结合;通过CCK8测定细胞增殖;采用Transwell实验观察细胞的迁移情况;利用Western blot检测p-Erk水平变化.结果 CXCR4受体在NF1相关细胞WZJ中高表达,靶向CXCR4的拮抗多肽E5能够特异性结合WZJ细胞.E5的抗细胞增殖能力具有细胞选择性,对NF1细胞具有显著的增殖抑制作用.E5能显著降低趋化因子配体12(CXCL12)对NF1细胞的趋化迁移率.机制研究表明,E5通过抑制p-Erk的表达来抑制WZJ细胞对CXCL12刺激的反应.结论 本研究发现了一种可以与CXCR4受体高表达的NF1细胞有效结合的多肽,其能通过下调CX-CL12激活的Erk磷酸化抑制NF1细胞增殖和迁移,在NF1治疗方面具有转化应用潜力.

Objective The purpose is to screen antagonistic polypeptides of chemokine receptor 4(CXCR4)that have a strong binding effect on Neurofibromatosis type 1(NF1)cells,and to study their anti-proliferation and migration abilities on human normal Schwann cells and NF1 cells,and to reveal their underlying mecha-nisms.Methods The cell line WZJ derived from NF1 patients were taken as the research objects.The expression of CXCR4 receptor in the cells and the binding of polypeptides to the cells were detected by flow cytometry;Cell proliferation was determined by CCK8;The migration of cells was observed by transwell assay;The changes in p-Erk levels were detected by Western blot.Results The results showed that the CXCR4 receptor was highly ex-pressed in NF1-related WZJ cells,and the antagonistic polypeptide E5 targeting CXCR4 could specifically bind to WZJ cells.The anti-cell proliferation ability of E5 is cell-selective and has a significant inhibitory effect on the proliferation of cells with high expression of CXCR4.E5 could significantly inhibit the migration of NF1 cells chemotactic by CXCL12.Mechanism studies have shown that E5 inhibits the response of WZJ cells to CXCL12 stimulation by suppressing the expression of p-Erk.Conclusion The study discovered a polypeptide that could ef-fectively bind to NF1 cells with high expression of CXCR4 receptor.It could inhibit the proliferation and migra-tion of NF1 cells by down-regulating the phosphorylation of Erk activated by CXCL12 and has translational appli-cation potential in the treatment of NF1.

杨爱云;王建华;路媛芳;王秀伟;官臻;李莘;朱智强;孟洁;王智超;许海燕

首都儿科研究所,首都医科大学附属首都儿童医学中心转化医学研究室,北京 100020首都儿科研究所,首都医科大学附属首都儿童医学中心转化医学研究室,北京 100020北京工业大学化学与生命科学学部环境与病毒肿瘤学北京市重点实验室,北京 100124首都儿科研究所,首都医科大学附属首都儿童医学中心转化医学研究室,北京 100020首都儿科研究所,首都医科大学附属首都儿童医学中心转化医学研究室,北京 100020首都儿科研究所,首都医科大学附属首都儿童医学中心转化医学研究室,北京 100020首都儿科研究所,首都医科大学附属首都儿童医学中心转化医学研究室,北京 100020中国医学科学院基础医学研究所,北京协和医学院基础学院,北京 100005上海交通大学医学院附属第九人民医院整复外科,上海 200003中国医学科学院基础医学研究所,北京协和医学院基础学院,北京 100005

CXCR4/CXCL12轴CXCR4拮抗剂Ⅰ型神经纤维瘤病细胞增殖细胞迁移

CXCR4/CXCL12 axisCXCR4 antagonistneurofibromatosis type 1cell proliferationcell migration

《遵义医科大学学报》 2026 (1)

21-28,8

北京市自然科学基金资助项目(NO:7244291)首都儿科研究所青年基金资助项目(NO:QN-2025-29)首都儿科研究所研究基金资助项目(NO:JHYJ-2023-03).

评论